Predicting a Rise: SCHK Set to Reach $32

The Schwab 1000 Index ETF (SCHK) currently trades at $28.77, with an implied analyst target price of $32.02, indicating an 11.28% potential upside. Key underlying holdings include Immunovant Inc (IMVT), trading at $15.34 with a target of $43.77 (185.33% upside), Zeta Global Holdings Corp (ZETA), at $13.20 with a target of $26.31 (99.30% upside), and Revolution Medicines Inc (RVMD), priced at $40.38 with a target of $72.36 (79.21% upside).